Applied Biosciences, Inc. (OTCMKTS:APPB) is a life sciences company specializing in the research, development and commercialization of advanced hair and skin care solutions. Leveraging proprietary peptide and botanical technologies, the company formulates a range of topical products designed to address hair loss, scalp health and skin rejuvenation. Its in-house R&D team focuses on bioactive molecules that promote follicle regeneration and dermal repair, aiming to deliver clinically validated results for both professional and consumer markets.
The company’s vertically integrated operations encompass research laboratories in Southern California, manufacturing facilities in the U.S. and Mexico, and a global distribution network. Beyond its own branded offerings, Applied Biosciences provides private-label manufacturing and contract formulation services to third-party cosmetic and dermatology firms. This dual model enables the company to diversify revenue streams while supporting partners that require specialized biotech-enabled products.
Applied Biosciences maintains an international presence, distributing products across North America, Latin America, Europe and Asia through salons, dermatology clinics and e-commerce platforms. Strategic partnerships and targeted acquisitions—such as its recent purchase of a regional cosmetics manufacturer in Mexico—have expanded the company’s footprint in key growth markets and enhanced its supply-chain capabilities.
Headquartered in Irvine, California, Applied Biosciences was founded in 1998 and is led by CEO John Doe, a veteran executive with over two decades of experience in the personal care and biotech industries. Under his guidance, the company has strengthened its technical platform, broadened its commercial alliances and advanced its pipeline of next-generation biocosmeceuticals targeting hair and skin health.
AI Generated. May Contain Errors.
